Back to search results

VoiceLove App for Critically Ill Patients

This study is testing an app called VoiceLove, designed to help critically ill patients and their families communicate better. VoiceLove allows families and patients to securely share voice messages, which can be especially helpful if a patient can't speak. Researchers want to see if using VoiceLove, compared to standard care without the app, can improve how families engage with their loved ones, make patients and families more satisfied, and potentially reduce delirium (a state of confusion) in the Intensive Care Unit (ICU). You might be able to join if you are an adult patient, 18 years or older, who meets specific health criteria. The study aims to enroll 100 participants and will look at how engaged patients are during their hospital stay, up to 14 days.

Study design
This is an interventional study comparing the VoiceLove app to standard care. It plans to enroll 100 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Patient engagement will be assessed for up to 14 days during acute hospitalization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06923462

VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)

Recruiting
NAAges 18+InterventionalSupportive care
Vanderbilt University Medical Center
~100 participants
Updated 2025-08-27 on ClinicalTrials.gov
What's tested:Communication Application

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Assess engagement among patients during acute hospitalization
Measured over Up to 14 days

Conditions

Critical Illness
Intensive Care Medicine

Explore related trials

Critical Illness

Where it's being run

1 sites across 1 states
Tennessee1

Study leadership

  • E Wesley Ely, MD, MPH · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center

Who to contact

Christina Boncyk, MD, MPH
[email protected]
615-936-2857
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Attending physician refusal
Patient and/or surrogate refusal
Patient unable to consent and no surrogate available 2. Acute or chronic neurologic deficit precluding CAM-ICU assessments 3. Inability to understand English 4. Current enrollment in a study that does not allow co-enrollment 5. Prisoners 6. Expected death or comfort measures within 24 hours of enrollment or lack of commitment to intervention by family or the medical team (e.g., likely to withdraw life support measures within 24 hours of enrollment). 7. Bilateral Deafness

What this trial measures

  • Assess engagement among patients during acute hospitalizationUp to 14 days

    Within the intervention group and control groups, engagement will be assessed through survey administered at ICU discharge